Hepatotoxicity Associated with Immune Checkpoint Inhibitors in Clinical Practice: A Study Leveraging Data from the US Food and Drug Administration's Adverse Event Reporting System-Reference-Cited by-同舟云学术

Hepatotoxicity Associated with Immune Checkpoint Inhibitors in Clinical Practice: A Study Leveraging Data from the US Food and Drug Administration's Adverse Event Reporting System

Published:2023-02 Issue:2 Volume:45 Page:151-159
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Yang Hui,Wang Haozhou,Zhou Xiaoguang,Zhang Xiaodong^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference28 articles.

1. Clinical features of immune-mediated hepatotoxicity induced by immune checkpoint inhibitors in patients with cancers;Yamamoto;J Cancer Res Clin Oncol,2021

3. Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors;De Martin;JHEP Rep,2020

4. Immune checkpoint inhibitor-related hepatotoxicity: a review;Remash;World J Gastroenterol,2021

5. Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies;Mizuno;J Gastroenterol,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatobiliary complications of immune checkpoint inhibitors in cancer;Exploration of Targeted Anti-tumor Therapy;2024-07-26

2. The ABC of Immune-Mediated Hepatitis during Immunotherapy in Patients with Cancer: From Pathogenesis to Multidisciplinary Management;Cancers;2024-02-15

3. Severe and fatal adverse events of immune checkpoint inhibitor combination therapy in patients with metastatic renal cell carcinoma: a systematic review and meta-analysis;Frontiers in Immunology;2023-06-19

4. Immune checkpoint inhibitors: significant risk of hepatotoxicity;Reactions Weekly;2023-02-11